BRKTX
Price
$17.60
Change
+$0.14 (+0.80%)
Updated
Sep 16 closing price
Net Assets
113.31M
RNWAX
Price
$90.29
Change
+$0.57 (+0.64%)
Updated
Sep 16 closing price
Net Assets
74.08B
Interact to see
Advertisement

BRKTX vs RNWAX

Header iconBRKTX vs RNWAX Comparison
Open Charts BRKTX vs RNWAXBanner chart's image
MFS Blended Research Em Mkts Eq R3
Price$17.60
Change+$0.14 (+0.80%)
VolumeN/A
Net Assets113.31M
American Funds New World R1
Price$90.29
Change+$0.57 (+0.64%)
VolumeN/A
Net Assets74.08B
BRKTX vs RNWAX Comparison Chart in %
Loading...
View a ticker or compare two or three
VS
BRKTX vs. RNWAX commentary
Sep 17, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is BRKTX is a Buy and RNWAX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
RNWAX has more cash in the bank: 74.1B vs. BRKTX (113M). BRKTX pays higher dividends than RNWAX: BRKTX (1.90) vs RNWAX (0.00). BRKTX was incepted earlier than RNWAX: BRKTX (10 years) vs RNWAX (23 years). BRKTX (1.95) is less costly to investors than RNWAX (1.66). BRKTX is a more actively managed with annual turnover of: 58.00 vs. RNWAX (37.00). BRKTX has a lower initial minimum investment than RNWAX: BRKTX (0) vs RNWAX (250). BRKTX annual gain was more profitable for investors over the last year : 28.72 vs. RNWAX (16.13). BRKTX return over 5 years is better than : 49.94 vs. RNWAX (25.94).
BRKTXRNWAXBRKTX / RNWAX
Total Expense Ratio1.241.6675%
Annual Report Gross Expense Ratio1.951.66117%
Fund Existence10 years23 years-
Gain YTD27.62922.627122%
Front LoadN/AN/A-
Min. Initial Investment0250-
Min. Initial Investment IRAN/AN/A-
Net Assets113M74.1B0%
Annual Yield % from dividends1.900.00-
Returns for 1 year28.7216.13178%
Returns for 3 years62.5146.78134%
Returns for 5 years49.9425.94193%
Returns for 10 years103.5189.51116%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
STVN27.231.00
+3.81%
Stevanato Group SpA
DNTH37.470.43
+1.16%
Dianthus Therapeutics
SIMA10.46N/A
N/A
SIM Acquisition Corp I
FERAU10.50N/A
N/A
Fifth Era Acquisition Corp I
CPIX3.36-0.02
-0.59%
Cumberland Pharmaceuticals